GBGB2016463.8A
GB202016463D0
(en)
|
2020-10-16 |
2020-10-16 |
Product
|
CA3182337A
CA3182337A1
(en)
|
2020-10-16 |
2021-10-18 |
Nucleic acid encoding an anti-vegf entity and a negative complement regulator and uses thereof for the treatment of age-related macular degeneration
|
KR1020227041935A
KR20230088630A
(en)
|
2020-10-16 |
2021-10-18 |
Nucleic acids encoding anti-VEGF entities and negative complement regulators and their use for the treatment of age-related macular degeneration
|
PCT/GB2021/052689
WO2022079453A1
(en)
|
2020-10-16 |
2021-10-18 |
Nucleic acid encoding an anti-vegf entity and a negative complement regulator and uses thereof for the treatment of age-related macular degeneration
|
EP21801205.2A
EP4229076A1
(en)
|
2020-10-16 |
2021-10-18 |
Nucleic acid encoding an anti-vegf entity and a negative complement regulator and uses thereof for the treatment of age-related macular degeneration
|
MX2023004377A
MX2023004377A
(en)
|
2020-10-16 |
2021-10-18 |
Nucleic acid encoding an anti-vegf entity and a negative complement regulator and uses thereof for the treatment of age-related macular degeneration.
|
AU2021362770A
AU2021362770A1
(en)
|
2020-10-16 |
2021-10-18 |
Nucleic acid encoding an anti-VEGF entity and a negative complement regulator and uses thereof for the treatment of age-related macular degeneration
|
CR20230202A
CR20230202A
(en)
|
2020-10-16 |
2021-10-18 |
Nucleic acid encoding an anti-vegf entity and a negative complement regulator and uses thereof for the treatment of age-related macular degeneration
|
JP2022573176A
JP2023545229A
(en)
|
2020-10-16 |
2021-10-18 |
Nucleic acids encoding anti-VEGF entities and negative complement regulators and their use for the treatment of age-related macular degeneration
|
IL298527A
IL298527A
(en)
|
2020-10-16 |
2021-10-18 |
Nucleic acid encoding an anti-vegf entity and a negative complement regulator and uses thereof for the treatment of age-related macular degeneration
|
US17/928,803
US20230212275A1
(en)
|
2020-10-16 |
2021-10-18 |
Nucleic acid encoding an anti-vegf entity and a negative complement regulator and uses thereof for the treatment of age-related macular degeneration
|
DO2023000076A
DOP2023000076A
(en)
|
2020-10-16 |
2023-04-14 |
NUCLEIC ACID ENCODING AN ANTIVEGF ENTITY AND A NEGATIVE COMPLEMENT REGULATOR AND ITS USES FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
|
CL2023001072A
CL2023001072A1
(en)
|
2020-10-16 |
2023-04-14 |
Nucleic acid encoding an anti-vegf entity and a negative complement regulator; applications
|
CONC2023/0005981A
CO2023005981A2
(en)
|
2020-10-16 |
2023-05-10 |
Nucleic acid encoding an anti-vegf entity and a negative complement regulator and their uses for the treatment of age-related macular degeneration
|
ECSENADI202334907A
ECSP23034907A
(en)
|
2020-10-16 |
2023-05-11 |
NUCLEIC ACID THAT ENCODES AN ANTI-VEGF ENTITY AND A REGULATOR OF THE NEGATIVE COMPLEMENT AND ITS USES FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
|